DREAMQZ Chemical has an extensive product portfolio including polymers, monomers,
basic petrochemical products, and megatrend products and is growing to become the Global chemical company
based on the world-class production facilities and stable revenue generation.
major
products
Polymers
Polymers
Polymers are widely used starting from household goods in everyday life to agricultural, industrial, medical, automobile, and cutting-edge new materials.
Monomers
Monomers
LOTTE Chemical supplies products stably to the market through vertical integration of raw materials and products and strives to develop new products that meet the users’ needs.
Basic petrochemicals
Basic petrochemicals
The basic petrochemicals are high value-added products used as raw materials in construction, home appliance, and textile industries. LOTTE Chemical has a vertically integrated, efficient production structure from raw materials to final products.
Megatrend
Megatrend
LOTTE Chemical manufactures high-strength and high-permeability hollow fiber membranes using its in-house developed technologies and has been expanding the market share with applications in sewage and wastewater facilities.
about
dreamqz
Introduction of JYMed peptide manufacturer, a US FDA inspection manufacturer. Featured products:Cosemtic peptide, Peptide APIs, Custom peptides. Such as, semaglutide, liraglutide, Tirzepatide, oxytocin, GHK, GHK-CU, Acetyl Hexapeptide-8.etc. If you want to konw more, please contact
email:jymed@jymedtech.com
-
FOCUS
FOCUS
JUST FOR BETTER PEPTIDES
View Details -
Business philosophy
Business philosophy
healthy life
View Details -
JYMed's Credo
JYMed's Credo
Innovative thinking
View Details -
Business strategy
Business strategy
precision marketing
View Details -
Management concept
Management concept
people-oriented and scientific and technological innovation
View Details
news and information
Exciting News: JYMed’s Leuprorelin Acetate Passes Drug Registration Inspection
Recently, JYMed Technology Co., Ltd. announced that Leuprorelin Acetate, produced by its subsidiary Hubei JX Bio-Pharmaceutical Co., Ltd., has successfully passed the drug registration inspection. Original Drug Market...
Congratutlation JYMed’s Tirzepatide Completes US-DMF Filing
JYMed Technology Co., Ltd. is pleased to announce that its product, Tirzepatide, has successfully completed the Drug Master File (DMF) registration with the U.S. FDA (DMF Number: 040115) and received the FDA's Acknowl...
JYMed Attends PCT 2024 in Shanghai
PCT2024 Personal Care Technology Summit & Exhibition is a highly influential event in the Asia-Pacific region, focusing on technology exchange and exhibitions in the personal care products industry.The forum will cover various aspects of the personal care industry, including technological in...